Kadcyla (ado-trastuzumab emtansine) - Roche
Aidixi (disitamab vedotin) - Pfizer, RemeGen
TAA013 - BioDlink
AiWeiDa (trastuzumab rezetecan) - Jiangsu Hengrui Pharma
Sertaly (trastuzumab botidotin) - Sichuan Kelun Pharma
Perjeta (pertuzumab) - Roche
PF-06804103 - Pfizer
AiRuiNi (pyrotinib) - Jiangsu Hengrui Pharma
trastuzumab envedotin (DP303c) - CSPC Pharma
DX126-262 - Hangzhou DAC Biotech
lapatinib - Generic mfg.
anvatabart opadotin (JNJ-0683) - J&J
BAT8001 - Bio-Thera Solutions
trastuzumab vedotin (MRG002) - Lepu Biopharma
https://www.abstractsonline.com/pp8/#!/10828/presentation/10313
 
Herui Yao; Min Yan; Zhongsheng Tong; Xinhong Wu; Min-Hee Ryu; Jee Hyun Kim; John Park; Yahua Zhong; Weiqing Han; Caigang Liu; Mark Voskoboynik; Qun Qin; Jian Zhang; Minal Barve; Ana Acuna-Villaorduna; Vinod Ganju; Seock-Ah Im; Changsheng Ye; Yongmei Yin; Amitesh C. Roy; Li-Yuan Bai; Yung-Chang Lin; Chia-Jui Yen; Hui Li; Ki Young Chung; Shanzhi Gu; Jun Qian; Yuee Teng; Yiding Chen; Yu Shen; Kaijing Zhao; Shangyi Rong; Xiaoyu Zhu; Erwei Song
 
Mar 14, 2023
 
Prev Next